Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial peptidoglycan beta-(1,4)-glycosidic bond is the fundamental structural linkage that connects N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) to form the glycan backbone of the bacterial cell wall (Salton & Kim, 1996, Medical Microbiology). This polymer provides the mechanical strength and rigidity required for bacteria to maintain their shape and survive high internal osmotic pressures (Schleifer & Kandler, 1972, Bacteriological Reviews). This specific bond is the primary target of the innate immune enzyme lysozyme (muramidase), which catalyzes its hydrolysis, leading to the loss of cell wall integrity and subsequent osmotic lysis of the bacterium (Raghavan & Groisman, 2015, Annual Review of Microbiology). While most clinical antibiotics like beta-lactams inhibit the synthesis or cross-linking of peptidoglycan, the NAM-NAG glycosidic bond represents a target for degradative enzymes and antimicrobial peptides (Callewaert & Michiels, 2010, Journal of Biosciences). Therapeutic interest in this target often focuses on the use of exogenous lysozymes or engineered endolysins to treat multi-drug resistant infections, particularly those caused by Gram-positive pathogens. However, the rapid breakdown of this bond can release pro-inflammatory peptidoglycan fragments, such as muramyl dipeptide, which may trigger systemic inflammatory responses through NOD-like receptors (Callewaert & Michiels, 2010, Journal of Biosciences).
Enzymatic hydrolysis of the beta-(1,4)-glycosidic linkage between N-acetylmuramic acid and N-acetylglucosamine residues in the peptidoglycan backbone.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial peptidoglycan beta-(1,4)-glycosidic bond.